NUDT1 and lung carcinoma: NUDT1 overexpression has been documented in several cancers [20–23], including renal-cell carcinomas [24], brain tumors [25, 26], lung cancer [20, 27], gastric cancer [28], and esophageal squamous cell carcinomas [29].